Menu
Washingtoner
  • Home
  • Business
  • Technology
  • Arts
  • Construction
  • Real Estate
  • Health
  • Software
  • Property
Washingtoner

First Choice Neurology Pioneering Neurologists Administer the New FDA-Approved Drug Kisunla
Washingtoner/10263199

Trending...
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
  • The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
  • New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
Kisunla FDA Approved for Alzheimers
JUPITER, Fla. - Washingtoner -- First Choice Neurology, the largest neurology group in the United States, is set to make medical history next week as Dr. Jennifer Buczyner and Dr. Jeff Gelblum are among the first physicians in the country to administer the newly FDA-approved drug Kisunla to patients. This groundbreaking development marks a significant milestone in neurological care, offering new hope to patients battling a range of neurological conditions.

Kisunla, by Eli Lilly represents a promising advancement in neurology, specifically targeting Alzheimer's disease and dementia. Kisunla is used to treat adults with early symptomatic Alzheimer's disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.

Dr. Jeff Gelblum, Neurologist in Aventura, Florida, has significant experience using anti-amyloid infusion therapy for his patients with mild cognitive impairment and mild Alzheimer's disease. He has many patients taking Leqembi with which was FDA approved in July 2023.

He is also looking forward to using Kisunla in his patients for the same conditions and differentiates the two products, accordingly: "The two drugs target the same endpoint, reduction of brain amyloid plaque which is a marker of Alzheimer's disease. Leqembi is given twice a month for a full 18 months. Kisunla is once a month and may be able to be stopped as soon as six months, based upon clearance of amyloid plaque on a follow up brain PET scan. Leqembi has a lower incidence of side effects of brain swelling and bleeding."

More on Washingtoner
  • Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
  • Radarsign Tackles Intersection Safety with Launch of Grid-Free Solar LED Stop Sign
  • Miami Real Estate Agent Drastically Increases Interest In Homes
  • Adostics & Genmega Announce the Introduction of A-POD
  • Erie Home Celebrates 100th Location, Cementing Coast-to-Coast Footprint

Gelblum notes, "that a patient who is unable to go for twice monthly infusions and eager to possibly conclude treatment in as soon as six months, who can also assume the greater safety risk, would be a good candidate for the new treatment."

Dr. Jennifer Buczyner, Neurologist in Jupiter, Florida said, "The approval of Kisunla offers another opportunity for patients with mild cognitive impairment or mild dementia and brings those with mild cognitive impairment to early medical attention. In studies, Kisunla slowed cognitive and functional decline by up to 35 percent compared to placebo at 18 months and reduced patients' risk of progressing to the next clinical stage of disease by up to 39 percent.  We at First Choice Neurology are very excited to offer anti-amyloid therapies to our South Florida communities."

The introduction of Kisunla underscores First Choice Neurology's commitment to pioneering treatments that transform the landscape of neurological care. As the first physicians in the United States to administer Kisunla, Dr. Gelblum and Dr. Buczyner exemplify the group's leadership in bringing cutting-edge therapies to patients.

More on Washingtoner
  • LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
  • Spokane: SPD Investigates Several Intentionally Set Fires
  • Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
  • City of Spokane Announces New Deputy Police Ombuds
  • NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI

About First Choice Neurology
First Choice Neurology is the largest neurology group in the United States with over 60 Care Centers in multiple Florida counties and services at more than 45 major hospitals. The group provides comprehensive neurological care for patients with a wide range of conditions including Alzheimer's disease, dementia, epilepsy, migraines, multiple sclerosis, Parkinson's disease, sleep disorders, strokes, traumatic brain injuries, and more. With a commitment to innovation and patient-centered care, First Choice Neurology continues to lead advancements in neurological treatments nationwide.

For more information about Kisunla and First Choice Neurology, visit fcneurology.com

Contact
First Choice Neurology
***@fcneurology.net


Source: First Choice Neurology

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
  • Larry Haight's Residential Roofing Celebrates 40 Years of Excellence in the Pacific Northwest
  • Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
  • Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
  • SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
  • From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
  • New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
  • Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
  • Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
  • $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
  • The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
  • Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
  • New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
  • The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
  • Digital Watchdog Launches New myDW Cloud Services
  • Stan Fitzgerald Appointed Acting Press Secretary for Veterans for America First VFAF Georgia State Chapter
  • Drone Light Shows Emerge as the New Standard in Live Event Entertainment
  • Lore Link is Here to Help Organize Your Game
  • Spokane: Underhill Sport Court Renovation Ribbon Cutting July 3, 10 a.m.
_catLbl0 _catLbl1

Popular on Washingtoner

  • Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 217
  • ASI Accelerates iMIS® Innovation by Acquiring CSI's Product Suite and Expert Team - 174
  • Keebos Launches New Universal Pearl Strap That Attaches to Any Phone Case - 165
  • Integris Composites Joins Paris Air Show at USA Pavilion - 145
  • Last Call - Submit Your Proposal for the 2025 OpenSSL Conference in Prague - 138
  • A Cosmic Banter: William Shatner & Neil deGrasse Tyson Go Wild on The Late Show with Stephen Colbert - 128
  • Patrick Aloni Joins Historic Gold and Copper Discovery in Argentina with Multimillion-Dollar Stake - 120
  • SheepFeast Launches "1 Million Discipled" Global Initiative to Empower Disciple-Making Around the World - 114
  • Sploot Vets and DeepScan Launch Exclusive Regional U.S. Partnership to Bring Breakthrough Pet DNA Test to Market - 104
  • Evluma and LED Roadway Lighting Ltd. Join Forces to Drive Innovation

Similar on Washingtoner

  • Pyro Marketing Opens New Digital Marketing Company in Saint Petersburg to Power Growth for Fitness and Ecommerce Brands
  • Dr. John Salerno of Salerno Wellness Introduces Their New Full Body Capsule for Advanced LED Light Therapy Patient Treatments
  • Heartfelt Dreams Foundation Launches Campaign to Build CHD Hospital
  • K Spa in Bellevue Now Accepts HSA and FSA for Medically Necessary Massage Therapy
  • Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
  • West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
  • Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
  • New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
  • Digital Watchdog Launches New myDW Cloud Services
  • Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute